Journal article
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019
- Abstract:
-
Renewed interest in developing vaccines against Neisseria gonorrhoeae has been sparked by the increasing threat of gonococcal antimicrobial resistance (AMR) and growing optimism that gonococcal vaccines are biologically feasible. Evidence suggests serogroup B Neisseria meningitidis vaccines might provide some cross-protection against N. gonorrhoeae, and new gonococcal vaccine candidates based on several approaches are currently in preclinical development. To further stimulate investment and a...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Funding
NIAID NIH HHS
More from this funder
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vaccine Journal website
- Volume:
- 38
- Issue:
- 28
- Pages:
- 4362-4373
- Publication date:
- 2020-04-28
- Acceptance date:
- 2020-02-25
- DOI:
- EISSN:
-
1873-2518
- ISSN:
-
0264-410X
- Pmid:
-
32359875
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1179543
- Local pid:
- pubs:1179543
- Deposit date:
- 2021-10-08
Terms of use
- Copyright holder:
- World Health Organization
- Copyright date:
- 2020
- Rights statement:
- Copyright 2020 World Health Organization; licensee Elsevier.This is an open access article under the CC BY IGO license (http://creativecommons.org/licenses/by/3.0/igo/).
- Licence:
- Other
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record